Mankind Pharma sets a new benchmark launches 120 Premium DMF Quality Drugs for Indian Patients
Mumbai,30 August 2023: In its steadfast commitment to enhancing quality healthcare access, Mankind Pharma, a leading pharmaceutical company is proud to unveil a significant stride with the introduction of 120 DMF (Drug Master File) Quality Medicines in the Indian market. Committed to delivering exceptional healthcare solutions at affordable rates, Mankind Pharma’s initiative aims to ensure universal access to medicines of international calibre.
India stands as a global leader in offering generic medicines that adhere to the stringent DMF quality standards set for Active Pharmaceutical Ingredients (APIs). Mankind Pharma takes a pioneering step by introducing DMF quality API in the Indian market, which is manufactured in a US FDA-approved plant. Thus, the final medicine is always one of the best quality with better efficacy. DMF Quality API represents a pinnacle of excellence that surpasses conventional standards. The medicines in the USA comply with stringent USFDA’s norms for quality, safety, and effectiveness; defined by DMF (Drug Master File). The Drug Master File (DMF) has all the information on an API (Active Pharmaceutical Ingredient/Raw material for Medicine). It provides all the information on the manufacturing, stability, quality, packaging, purity, and impurity profile for authorities to ensure that medicines have the best quality and efficacy. DMF quality API is purer than normal API because it follows US pharmacopeia and is manufactured in USFDA-approved plants for medicines that are of best quality and efficacy.
Mr Rajeev Juneja, Vice Chairman & Managing Director, of Mankind Pharma says, ” Introducing over 120 DMF Quality Medicines reflects Mankind Pharma’s unwavering commitment to delivering healthcare solutions of exceptional quality. At Mankind, we believe that every Indian, irrespective of their economic background, has the right to get medicines of International quality. As we launch this comprehensive range, we aim to bridge gaps in healthcare accessibility, ensuring that every individual in India can access medicines that are of the highest USFDA approved standards. This initiative resonates with our motto of ‘Serving Life,’ and underscores our dedication to enriching lives through accessible and reliable healthcare”
The company’s commitment to offering premium healthcare solutions that cater to all strata of society is reinforced by this ground-breaking initiative.